Biopharma groups laud USMCA's IP protections

A slew of biopharmaceutical organizations is lauding the U.S.-Mexico-Canada Agreement for its “vital” intellectual property protections, according to a letter sent this week to U.S. Trade Representative Robert Lighthizer. The Michigan Biosciences Industry Association the Texas Healthcare and Bioscience Institute and dozens of similar groups, as well as business associations, say in the letter that they “commend” the deal for “new standards [that] will drive investment, innovation, exports, and bioscience job creation for U.S. innovators – the lifeblood of America’s...